Aktionärsstruktur

Inhaber in %
Freefloat 86,57
Nippon Life Insurance Co. 5,63
The Vanguard Group, Inc. 3,78
Capital Research & Management Co. (Global Investors) 2,93
Nomura Asset Management Co., Ltd. 2,89
Causeway Capital Management LLC 2,36
Mondrian Investment Partners Ltd. 2,26
Takeda Science Foundation 2,25
Wellington Management Co. LLP 1,99
BlackRock Fund Advisors 1,78
Barclays Bank Plc (Private Banking) 1,77
State Street Global Advisors Ltd. 1,67
Nikko Asset Management Co., Ltd. 1,60
Takeda Pharmaceutical Employee Incentive Plan 1,54
Daiwa Asset Management Co. Ltd. 1,37

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2013 2014 2015 2016 2017 2018
Personal am Ende des Jahres 30.481 31.225 31.328 31.168 29.900 27.230
Umsatz pro Mitarbeiter in Mio. EUR 51,09 54,18 56,75 57,99 57,93 65,02

Bilanz (in Mio. EUR) - Aktiva

2013 2014 2015 2016 2017 2018
Summe Umlaufvermögen 1.455.081 1.592.536 1.520.072 1.373.787 1.260.662 1.078.808
Summe Anlagevermögen 2.720.449 3.348.192 2.885.873 2.770.900 3.097.962 3.036.235
Summe Aktiva 3.955.599 4.569.144 4.296.192 3.824.085 4.355.782 4.106.463

Bilanz (in Mio. EUR) - Passiva

2013 2014 2015 2016 2017 2018
Gesamtverschuldung/ -verbindlichkeiten 560.508 877.453 748.826 822.208 1.203.701 1.038.811
Summe Fremdkapital 1.732.240 2.028.509 2.090.016 1.812.882 2.406.818 2.089.054
Summe Eigenkapital 2.223.359 2.540.635 2.206.176 2.011.203 1.948.965 2.017.409
Summe Passiva 3.955.599 4.569.144 4.296.192 3.824.085 4.355.783 4.106.463

Adresse

4-1-1 Dosho-machi, 540-8645 Osaka
Telefon 81662042111
Fax 81662042880
Internet http://www.takeda.co.jp

Management

Andrew S. Plump MD, PhD
Director, Chief Medical & Scientific Officer
Christophe Weber, PhD
President, CEO & Representative Director
Costa Saroukos
Chief Financial Officer
David Osborne
Global Human Resources Officer & Executive Officer
Emiko Higashi, MBA
Independent Outside Director
Giles Platford
President-Europe & Canada
Haruhiko Hirate
Corporate Communications & Public Affairs Officer
Iwaaki Taniguchi
Senior Manager-Finance
Jean-Luc Butel, MBA
Independent Outside Director
Kenji Sawai
Manager-Personnel & Administration
Koji Hatsukawa, CPA
Independent Outside Director
Masahiro Sakane
Independent Outside Director
Masato Iwasaki, PhD
Director & President-Japan Pharma Business Unit
Michel Orsinger
Independent Outside Director
Norimasa Takeda
Head-Consolidated Accounting
Satoru Takemoto
General Manager-Sales
Shinji Ninomiya
Manager-Research & Development
Shiro Kuniya
Independent Outside Director
Takashi Okubo
Global Head-Investor Relations & Global Finance
Toshiyuki Shiga
Independent Outside Director
Yasuhiko Yamanaka
Managing Director & Head-Globalization
Yoshiaki Fujimori, MBA
Independent Outside Director
Yoshihiro Nakagawa
Executive Officer & Global General Counsel